On the one hand, elevated circulating levels of S100B have been associated with risk of Schizophrenia (SCZ), bipolar disorders (BIP), major depression disorder (MDD), autism spectral disorders (ASD), and Alzheimer’s disease (AD) [11, 13–18]. This evidence concerns the gene S100B and major depressive disorder.